Keywords: Sphingolipid; Insulin resistance; NAFLD;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Multiple molecular targets in the liver, adipose tissue and skeletal muscle in ginger-elicited amelioration of nonalcoholic fatty liver disease
Keywords: ACC; acetyl-CoA carboxylase; ACO; acyl-CoA oxidase; ADIPO-IR; adipose tissue insulin resistance; AMKP; AMP-activated proteinkinase; AUC; the area under the curve; ChREBP; carbohydrate response element binding protein; CPT; carnitine palmitoyltransferase;
Keywords: Type 1 diabetes; Hepatitis C; Autoimmune hepatitis; NAFLD; Liver stiffness; Transient elastography;
Keywords: 20-HETE; 20-hydroxyeicosatetraenoic acid; ACE; angiotensin converting enzyme; ACEI; angiotensin converting enzyme inhibitor; Agt; angiotensinogen; Agt â/â; Â Agt whole body knock-out mouse model; AMPK; AMP-activated protein kinase; Ang II; angiotensin
Keywords: genome wide; Hispanic; fatty liver; fibrosis; pediatrics; BMI; Body mass index; CRN; Clinical Research Network; GWAS; Genome-wide association study; NAFLD; Nonalcoholic fatty liver disease; NAS; Nonalcoholic fatty liver disease activity score; NASH; Nonal
Keywords: Dietary Treatment; NAFLD; Pediatric; Overweight; AUC; area under the curve; CISI; Composite Insulin Sensitivity Index; DNL; de novo lipogenesis; IQR; interquartile range; ISR; insulin secretion rate; L/W; lipid/water; MR; magnetic resonance; NAFLD; non-al
Keywords: Fontan circulation; congestive hepatopathy; hepatic fibrosis; congenital heart disease; adult congenital heart disease; AARCC; Alliance for Adult Research in Congenital Cardiology; ALT; alanine aminotransferase; AST; aspartate aminotransferase; CT; comput
Keywords: Dihydroceramide; Autophagy; NAFLD; Fibrosis; Fatty acid/Metabolism; Sphingolipids;
Keywords: Fatty liver; Lifestyle intervention; NAFLD; OGTT; Prediction; Triglycerides;
Keywords: DLA-M; dietary lipid adsorbent-montmorillonite; Epi-WAT; epididymal white adipose tissue; FFA; free fatty acid; HFD; high fat diet; HOMA-IR; homeostasis model index of insulin resistance; IBS; irritable bowel syndrome; IGTT; introperitoneal glucose tolera
Keywords: Baicalin; Baicalein; Flavonoids; Chemoprevention; Inflammatory diseases; 6-OHDA; 6-hydroxydopamine; 12-LOX; 12-lipoxygenase; AIDS; acquired immunodeficiency disorder syndrome; AhR; aryl hydrocarbon receptor; AIH; autoimmune hepatitis; AICAR; 5-aminoimidaz
Keywords: ATF6; activating transcription factor 6; CHOP; C/EBP-homologous protein; CVD; cardiovascular disease; eIF2α; eukaryotic translation initiator factor 2α; ER; endoplasmic reticulum; GRP78; glucose regulated protein 78; IDL; intermediate-density lipoprotei
Keywords: AGB; adjustable gastric band; BMI; body mass index; CDC; Centers for Disease Control and Prevention; LSG; laparoscopic sleeve gastrectomy; NAFLD; nonalcoholic fatty liver disease; OSA; obstructive sleep apnea; RYGB; Roux-en-Y gastric bypass; T2DM; type 2
Keywords: NAFLD; NASH; Treatment; Clinical trials; Nonantifibrotics;
Keywords: 5-HT(2B); 5-hydroxytryptamine 2B receptor; ACE; angiotensin-converting enzyme; AMPK; AMP-activated protein kinase; ARB; AT1R blocker; ASK1; apoptosis signal-regulating kinase 1; AT1R; angiotensin II type 1 receptor; ATX; autotaxin; BDL; bile duct ligation
Keywords: CHD; coronary heart disease; CI; confidence interval (CI); CKD; chronic kidney disease; CVD; cardiovascular disease; CRP; C-reactive protein; eGFR; estimated glomerular filtration rate; FPG; fasting plasma glucose; GGT; gamma-glutamyltransferase; HR; haza
Keywords: Sarcopenic obesity; Metabolic syndrome; Microbiota; Fatty liver disease; Multidisciplinary; Weight maintenance; BIA; bio-electric impedance analysis; BMI; body mass index; CBW; current body weight; CKD; chronic kidney disease; COPD; chronic obstructive pu
Keywords: AMPKα2; AMP-activated protein kinase α2; CT; computerized tomography; CI; confidence interval; EPIC-Norfolk; European Investigation into Cancer; HbA1c; higher hemoglobin A1c; HOMA-β; homeostatic model assessment method; MKP1; MAP kinase phosphatase-1;
Keywords: Drugs; NAFLD; Prognosis; Risk score; Treatment;
Keywords: NAFLD; Mediterranean diet; KIDMED; Obesity; Children;
Keywords: NAFLD; nonalcoholic fatty liver disease; ALD; alcoholic liver disease; TLRs; Toll-like receptors; NLRs; Nod-like receptors; NASH; nonalcoholic steatohepatitis; BT; bacterial translocation; HE; hepatic encephalopathy; ACLF; acute on chronic liver failure;
Keywords: Body Weight; Waist Size; Risk Factor; Disease Progression; ALT; alanine aminotransferase; BMI; body mass index; CI; confidence interval; cIMT; carotid intima-media thickness; cplaques; carotid plaques; MetS; metabolic syndrome; NAFLD; nonalcoholic fatty l
Keywords: Cost-effectiveness; Liver disease; Alcohol; Hepatitis C; NAFLD; Serum aminotransferases; Liver function tests;
Keywords: BMI; body mass index; CI; confidence interval; DM; diabetes mellitus; MRI; magnetic resonance imaging; NAFLD; Non-alcoholic fatty liver disease; NAFPD; Non-alcoholic fatty pancreas disease; RR; relative risk; VAT; visceral adipose tissue area; WC; waist c
Keywords: Sensitivity; Specificity; Fatty Liver; Liver Fibrosis; Noninvasive Diagnosis; APRI; aspartate transaminase to platelet ratio index; CI; confidence interval; FIB-4; Fibrosis-4; NAFLD; nonalcoholic fatty liver disease; NFS; NAFLD fibrosis score;
Keywords: Cirrhosis; Overweight; Body Weight; Waist Size; ABSI; A Body Shape Index; BMI; body mass index; CI; confidence interval; HCC; hepatocellular carcinoma; HR; hazard ratio; NAFLD; nonalcoholic fatty liver disease; WC; waist circumference; WHR; waist/hip rati
The effect of cannabinoid receptor 1 blockade on hepatic free fatty acid profile in mice with nonalcoholic fatty liver disease
Keywords: NAFLD; Endocannabinoid system; Rimonabant; CB1 receptor blockade; Free fatty acid profile; Mice;
Keywords: CARDIA Study; NASH; Heart Disease; NAFLD; A; late (atrial) transmitral velocity; BMI; body mass index; CAC; coronary artery calcification; CARDIA; Coronary Artery Risk Development in Young Adults study; CI; confidence interval; CT; computed tomography; CV
Keywords: Non-alcoholic fatty liver disease; NAFLD; Metabolic disease; Hedgehog; SHH; GLI2; NASH; Liver fibrosis; Cirrhosis; Hepatocellular carcinoma; Holoprosencephaly; HPE;
Keywords: ALT; alanine aminotransferase; ChREBP; carbohydrate response element binding protein; CXCL10; CXC motif chemokine ligand 10; DGAT2; diglyceride acyltransferase 2; DNL; de novo lipogenesis; FAME; fatty acid methyl ester; FAS; fatty acid synthase; GAPDH; gl
Keywords: Mouse Model; Lipid Metabolism; 1-Carbon Metabolism; Prognostic; ALT; alanine aminotransferase; DG; diglycerides; DMR; differentially methylated DNA regions; FA; fatty acids; GSH; glutathione; JC-1; 5,5,6,6-tetrachloro-1,1,3,3-tetraethylbenzimidazolyl-carb
Keywords: ATP; adenosine triphosphate; Ca2+; Â calcium; CamK; calmodulin-dependent kinase; ChREBP; carbohydrate response element binding protein; CypD; cylophilin D; DGAT2; diacylglycerol acyltransferase 2; ER; endoplasmic reticulum; FOXO1; Forkhead box O1; G6P; gl
Keywords: FLINT; NAFLD; Direct Comparison; Non-Invasive; AUROC; area under receiving operating curve; CI; confidence interval; CRN; clinical research network; EOT; end of treatment; MRI; magnetic resonance imaging; NAFLD; nonalcoholic fatty liver disease; NASH; non
Keywords: Liver; Pancreas; Gallbladder; Cancer; Fat; BMI; body mass index; CI; confidence interval; GERD; gastroesophageal reflux disease; HCC; hepatocellular carcinoma; LES; lower esophageal sphincter; NAFLD; nonalcoholic fatty liver disease; NASH; nonalcoholic st
Keywords: ACC; acetyl-CoA carboxylase; ApoB; apolipoprotein B; ApoCII; apolipoprotein C-II; APPL-1; adaptor protein containing pleckstrin homology domain, phosphotyrosine binding domain and a leucine zipper motif; CD36; fatty acid translocase; CETP; cholesteryl est
Keywords: Bile Acids; FXR; TGR5; Meta-Inflammation; apo; apolipoprotein; ASBT; apical sodiumâdependent bile acid transporter; BA; bile acid; BAS; bile acid sequestrant; BAT; brown adipose tissue; BSH; bile salt hydrolase; CA; cholic acid; CCK; cholecystokinin; CD
Keywords: ACSL; Acyl-CoA synthetases; ANOVA; analysis of variance; CHP; cumene hydroperoxide; CPT1; carnitine palmitoyltransferase 1; CRAT; carnitine acetyltransferase; DHB; 2,5-dihydroxybenzoic acid; FABP; fatty acid binding protein; FCCP; carbonyl cyanide-4-(trif
Keywords: AAPH; 2,2'-Azobis(2-amidinopropane) dihydrochloride; ALS; Amyotrophic lateral sclerosis; AMI; Acute myocardial infarction; BCD; Basal conjugated dienes; BMI; Body mass index; CAD; Coronary artery disease; CD; Conjugated dienes; CDAI; Crohn's disease activ
Keywords: LPS; lipopolysaccharide; NAFLD; nonalcoholic fatty liver disease; NASH; nonalcoholic steatohepatitis; TGF; transforming growth factor; TLR; toll like receptor; TNF; tumor necrosis factor;
Keywords: AR; androgen receptor; ER; estrogen receptor; HCC; hepatocellular carcinoma; MELD; Model for End-Stage Liver Disease; NAFLD; nonalcoholic fatty liver disease; NASH; nonalcoholic steatohepatitis; OS; overall survival;
Keywords: NAFLD; Cardiovascular disease; Type 1 diabetes;
Keywords: Fibroscan; Insulin resistance; NAFLD; Normal value;
Keywords: DEHP; NAFLD; Lipid accumulation; Inflammation;
Keywords: Liver Cancer; MEC Study; Epidemiology; Visceral Adiposity; BMI; body mass index; CI; confidence interval; DXA; dual-energy x-ray absorptiometry; HCC; hepatocellular carcinoma; HR; hazard ratio; MEC; Multiethnic Cohort Study; MRI; magnetic resonance imagin
Keywords: BUN; blood urea nitrogen; FFA; free fatty acid; GH; growth hormone; HFD; high-fat diet; IGF-1; insulin-like growth factor-1; IL-6; interleukin-6; NAFLD; nonalcoholic fatty liver disease; STAT5; signal transducer and activator of transcription 5; STAT5 LKO
Keywords: ALT; aminotransferase; BMI; body mass index; CHS; Cardiovascular Health Study; CRP; C-reactive protein; IL6; interleukin 6; NAFLD; non-alcoholic fatty liver disease; NASH; non-alcoholic steatohepatitis; NMR; nuclear magnetic resonance; VLDL; very low-dens
Keywords: Nonalcoholic fatty liver disease; Lipid phenotype; Association; NAFLD; nonalcoholic fatty liver disease; NL; normolipemia; MetS; metabolic syndrome; HDL-C; high-density lipoprotein cholesterol; OR; Odds ratio; BMI; body mass index; BP; blood pressure; FPG
Keywords: ALT; alanine aminotransferase; BMP; bone morphogenetic protein; BT; bacterial translocation; CFU; colony-forming unit; DAMP; damage associated molecular patterns; FIAF; fasting-induced adipose factor; HSCs; hepatic stellate cells; IM; intestinal microbiot
Keywords: Liver transplantation; Machine perfusion; Recurrent disease; Donation after circulatory; Death; De novo cancer; AIH; autoimmune hepatitis; AMR; antibody mediated rejection; BMI; body metabolic index; HBV; hepatitis B Virus; CMV; cytomegalovirus; DBD; dona
Keywords: NAFLD; Race; Ethnicity; PNPLA;